Psoriasis drug offers treatment potential for type 1 diabetes

09/24/2013 | Medical News Today

The psoriasis drug alefacept was able to help the body produce its own insulin in a study of 49 patients with type 1 diabetes conducted by Indiana University and the Riley Hospital for Children in Indianapolis. Researchers identified alefacept because it targets the same specific T cells that attack insulin-producing cells in the pancreas of type 1 diabetes patients.

View Full Article in:

Medical News Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD